Steve Duffy

Steve Duffy

Digital Content Editor
Steve Duffy is the Digital Editor for MPR, part of the Medical Communications Group of Haymarket Media. He holds a BA in Media and Communications from Dundalk Institute of Technology and an MA in Journalism from Griffith College Dublin (both Ireland).

All articles by Steve Duffy

Investigational Treatment REN001 for Fatty Acid Oxidation Disorders Gets Orphan Drug Designation

The Food and Drug Administration (FDA) has granted Orphan Drug designation to REN001 (Reneo Pharmaceuticals) for the treatment of fatty acid oxidation disorders. REN001 is a selective peroxisome proliferator-activated receptor (PPAR) delta agonist currently being investigated in a phase 1b trial involving 12 patients with confirmed fatty acid oxidation disorders. The primary outcome measure of…

Next post in News Briefs